* Artivion Inc AORT.N reported a quarterly adjusted loss
of 39
cents per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of -10
cents. The mean expectation of six analysts for the quarter was
for a loss of 6 cents per share. Wall Street expected results to
range from -15 cents to 2 cents per share.
* Revenue rose 3.9% to $97.31 million from a year ago;
analysts
expected $100.82 million.
* Artivion Inc's reported EPS for the quarter was a loss
of 39
cents.
* The company reported a quarterly loss of $16.48 million.
* Artivion Inc shares had fallen by 1.2% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Artivion Inc is
$33.00
This summary was machine generated from LSEG data February 24 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.06 -0.39 Missed
Sep. 30 2024 -0.06 -0.05 Beat
Jun. 30 2024 -0.02 -0.05 Missed
Mar. 31 2024 -0.09 0.06 Beat